MX367220B - Gluconato de clorhexidina solubilizado en un monoacilglicerido hidrofobo. - Google Patents

Gluconato de clorhexidina solubilizado en un monoacilglicerido hidrofobo.

Info

Publication number
MX367220B
MX367220B MX2015002542A MX2015002542A MX367220B MX 367220 B MX367220 B MX 367220B MX 2015002542 A MX2015002542 A MX 2015002542A MX 2015002542 A MX2015002542 A MX 2015002542A MX 367220 B MX367220 B MX 367220B
Authority
MX
Mexico
Prior art keywords
chlorhexidine gluconate
monoacylglyceride
hydrophobic
solubilized
gluconate solubilized
Prior art date
Application number
MX2015002542A
Other languages
English (en)
Spanish (es)
Other versions
MX2015002542A (es
Inventor
B Ross Richard
P Menon Vinod
D Rule Joseph
Original Assignee
3M Innovative Properties Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3M Innovative Properties Co filed Critical 3M Innovative Properties Co
Publication of MX2015002542A publication Critical patent/MX2015002542A/es
Publication of MX367220B publication Critical patent/MX367220B/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • A61K8/375Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/43Guanidines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10General cosmetic use
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30Characterized by the absence of a particular group of ingredients
    • A61K2800/31Anhydrous
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • A61K2800/524Preservatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Detergent Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
MX2015002542A 2012-08-28 2013-08-27 Gluconato de clorhexidina solubilizado en un monoacilglicerido hidrofobo. MX367220B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261694080P 2012-08-28 2012-08-28
PCT/US2013/056802 WO2014035971A2 (en) 2012-08-28 2013-08-27 Chlorhexidine gluconate solubilized in a hydrophobic monoacylglyceride

Publications (2)

Publication Number Publication Date
MX2015002542A MX2015002542A (es) 2015-06-23
MX367220B true MX367220B (es) 2019-08-09

Family

ID=49151333

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015002542A MX367220B (es) 2012-08-28 2013-08-27 Gluconato de clorhexidina solubilizado en un monoacilglicerido hidrofobo.

Country Status (9)

Country Link
US (1) US20150238444A1 (enExample)
EP (1) EP2890362B1 (enExample)
JP (1) JP6158928B2 (enExample)
CN (1) CN104684536B (enExample)
AU (1) AU2013308992B2 (enExample)
BR (1) BR112015004178A2 (enExample)
CA (1) CA2882964A1 (enExample)
MX (1) MX367220B (enExample)
WO (1) WO2014035971A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2373270B8 (en) 2009-01-07 2023-04-12 entrotech life sciences, inc. Chlorhexidine-containing antimicrobial laminates
BR112015004600A2 (pt) 2012-08-28 2017-07-04 3M Innovative Properties Co composições de gluconato de clorexidina, sistemas e artigos de resina
US11039615B2 (en) 2014-04-18 2021-06-22 Entrotech Life Sciences, Inc. Methods of processing chlorhexidine-containing polymerizable compositions and antimicrobial articles formed thereby
WO2017160785A1 (en) 2016-03-18 2017-09-21 3M Innovative Properties Company Adhesive compositions with (meth) acrylic-based block copolymers
WO2020109934A1 (en) * 2018-11-30 2020-06-04 3M Innovative Properties Company Topical antimicrobial microemulsions with fluorescent materials
WO2021019339A1 (en) 2019-08-01 2021-02-04 3M Innovative Properties Company An antimicrobial device for an insertion needle
US12179472B2 (en) 2019-11-04 2024-12-31 Solventum Intellectual Properties Company Reinforced adhesive substrate
EP4061901A1 (en) 2019-11-20 2022-09-28 3M Innovative Properties Company Medical tapes with high optical clarity when over-taped
EP4259737A1 (en) 2020-12-11 2023-10-18 3M Innovative Properties Company Perforated tapes for medical applications

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1599159A (en) * 1977-02-08 1981-09-30 Roussel Lab Ltd Pharmaceutical compositions containing chlorhexidine
JPH02140167A (ja) * 1988-11-22 1990-05-29 Saraya Kk 手指消毒用組成物
JPH0399010A (ja) * 1989-09-13 1991-04-24 Taisho Pharmaceut Co Ltd 医薬組成物
US5093109A (en) * 1990-04-04 1992-03-03 Chanel, Inc. Cosmetic composition
US6458341B1 (en) * 1998-06-04 2002-10-01 3M Innovative Properties Company Devices with coatings containing chlorhexidine gluconate, compositions and methods
US20030031694A1 (en) * 2001-04-20 2003-02-13 3M Innovative Properties Company Controlled release particles
DE20204160U1 (de) * 2002-03-14 2002-07-04 Köhler Pharma GmbH, 64665 Alsbach-Hähnlein Hauptpflegemittel
AU2003282358A1 (en) * 2002-11-21 2004-06-15 J.P.M.E.D. Ltd. Compositions for treating infected skin and mucous membrane comprising an anti-microbial agent and an essential oil
US20050245738A1 (en) * 2004-05-03 2005-11-03 Lupin Ltd Stable bioavailable crystalline form or cefdinir and a process for the preparation thereof
US20050271611A1 (en) * 2004-06-08 2005-12-08 Shiseido Co., Ltd. Cosmetic
US20060205838A1 (en) * 2005-03-10 2006-09-14 Velamakanni Bhaskar V Hardenable antimicrobial dental compositions and methods
JP2007217394A (ja) * 2006-02-16 2007-08-30 I-Nage:Kk 医薬組成物
CN101489379B (zh) * 2006-10-27 2014-06-04 3M创新有限公司 抗微生物组合物

Also Published As

Publication number Publication date
MX2015002542A (es) 2015-06-23
JP2015526518A (ja) 2015-09-10
BR112015004178A2 (pt) 2017-07-04
EP2890362A2 (en) 2015-07-08
EP2890362B1 (en) 2020-11-11
AU2013308992B2 (en) 2016-06-23
WO2014035971A2 (en) 2014-03-06
CN104684536B (zh) 2018-01-12
US20150238444A1 (en) 2015-08-27
JP6158928B2 (ja) 2017-07-05
WO2014035971A3 (en) 2014-10-30
CA2882964A1 (en) 2014-03-06
CN104684536A (zh) 2015-06-03
AU2013308992A1 (en) 2015-03-12

Similar Documents

Publication Publication Date Title
MX367220B (es) Gluconato de clorhexidina solubilizado en un monoacilglicerido hidrofobo.
MX354749B (es) Composiciones de gluconato de clorhexidina, sistemas de resinas y articulos.
MX2015008627A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2016016666A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
EA201500582A1 (ru) Тройные фунгицидные смеси
MX2016015093A (es) Derivados de acido boronico y sus usos terapeuticos.
MX2016008448A (es) Conjugados de var2csa-farmaco.
SG195086A1 (en) Compounds containing hydrido-tricyano-borate anions
IN2014DN06104A (enExample)
PH12015500900B1 (en) A stabilized pemetrexed formulation
IT1404931B1 (it) Composizioni oftalmiche per la somministrazione di principi attivi liposolubili .
MX359769B (es) Metodos para descelularizar huesos.
MY161601A (en) Films and compositions comprising the same
MX2014010433A (es) Nueva forma cristalina de sulfato de sitagliptina.
MX2012010127A (es) Derivados de aminoindanos, su preparacion y su aplicacion en terapeuticos.
MX2014009750A (es) Composiciones antifungicas para el tratamiento de piel y uñas.
FR2972924B1 (fr) Composition cosmetique et dermatologique et leurs utilisations
MX358132B (es) Solucion de trombina y metodos de uso de esta.
EA201590651A1 (ru) Фармацевтическая композиция, содержащая ребамипид
MX345263B (es) Formulación de pexiganan estable.
MX367773B (es) Forma salina sólida de la alfa-6-mpeg6-o-hidroxicodona como agonistas opioides y sus usos.
AU2012240388A8 (en) Treatment regimens
MX351093B (es) Nuevos derivados de azetidina.
PH12015501428A1 (en) Antibacterial compounds
MX349487B (es) Composiciones de higiene bucal.

Legal Events

Date Code Title Description
FG Grant or registration